Caption Management’s United Therapeutics UTHR Stock Holding History

Caption Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.06M	Sell	9,333 -65,112	-87%	-$36.7M	0.02%	579
2026 Q1	$44.1M	Buy	74,445 +19,364	+35%	+$9.64M	0.26%	75
2025 Q4	$26.8M	Buy	55,081 +15,562	+39%	+$7.25M	0.18%	122
2025 Q3	$16.6M	Buy	39,519 +21,319	+117%	+$7.17M	0.13%	173
2025 Q2	$5.23M	Buy	18,200 +16,981	+1,393%	+$5.07M	0.06%	392
2025 Q1	$376K	Buy	+1,219	New	+$418K	﹤0.01%	1165
2022 Q4	–	Sell	-5,000	Closed	-$1.05M	–	1744
2022 Q3	$1.05M	Buy	+5,000	New	+$1.12M	0.01%	854
2021 Q4	–	Sell	-25,937	Closed	-$5.09M	–	1954
2021 Q3	$4.79M	Buy	+25,937	New	+$5.11M	0.05%	477

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Caption Management's UTHR Position: Q2 2026 in Review

Caption Management reduced its United Therapeutics (UTHR) stake by 87% in Q2 2026, selling an estimated $36.7M and leaving 9,333 shares worth $5.06M. The position accounts for 0.02% of the portfolio, ranked #579.

Caption Management first reported a position in UTHR in Q3 2021 and has held it in 8 quarters since. The position peaked at $44.1M in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Caption Management held 9,333 shares of United Therapeutics worth $5.06M as of Q2 2026.
Caption Management sold 65,112 United Therapeutics shares in Q2 2026, an estimated $36.7M.
United Therapeutics made up 0.02% of Caption Management's portfolio in Q2 2026, its #579 holding.
Caption Management first reported a position in United Therapeutics in Q3 2021 and has held it in 8 quarters since.
Caption Management's United Therapeutics position peaked at $44.1M in Q1 2026.
882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.